Re:C diff spores resist bleach and remain viable on surgical...
by mx20 on Friday November 24, 2023 @02:03AM
(#38401302)
Goldman Sachs Analyst thinks otherwise. The company behind the Hepatitis C cure seems to also not doing well with monetizing their cure. There are also countries like Brazil that just suspended the patent.
https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patie...